DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $69,000 | -46.1% | 3,425 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $128,000 | +45.5% | 3,425 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $88,000 | +17.3% | 3,425 | 0.0% | 0.00% | – |
| Q4 2020 | $75,000 | +33.9% | 3,425 | +9.6% | 0.00% | – |
| Q3 2020 | $56,000 | +180.0% | 3,125 | +303.2% | 0.00% | – |
| Q2 2020 | $20,000 | +100.0% | 775 | +40.9% | 0.00% | – |
| Q1 2020 | $10,000 | -16.7% | 550 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | +50.0% | 550 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | +60.0% | 550 | +77.4% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 310 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | +66.7% | 310 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 310 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | – | 310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |